Clinical Trial Update: Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial is planned to evaluate semaglutide for preventing posttransplant diabetes mellitus in kidney transplant recipients, and the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttransplant Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Kidney Transplant Recipient | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING